| 0 (0%) | 12-26 20:14 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 12.77 | 1-year : | 14.92 |
| Resists | First : | 10.93 | Second : | 12.77 |
| Pivot price | 10.71  |
|||
| Supports | First : | 10.53 | Second : | 10.27 |
| MAs | MA(5) : | 10.82  |
MA(20) : | 10.7 |
| MA(100) : | 10.45 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 67.3 |
D(3) : | 75.6 |
| RSI | RSI(14): 58.7 |
|||
| 52-week | High : | 10.93 | Low : | 8.56 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ EMD ] has closed below upper band by 36.7%. Bollinger Bands are 41% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 10.86 - 10.91 | 10.91 - 10.97 |
| Low: | 10.6 - 10.66 | 10.66 - 10.72 |
| Close: | 10.7 - 10.79 | 10.79 - 10.88 |
Thu, 25 Dec 2025
Athearn Genesis HO EMD FP45 review - trains.com
Fri, 19 Dec 2025
EMD: Emerging Market Debt CEF, Strong Double-Digit Yield, Outstanding Momentum (NYSE:EMD) - Seeking Alpha
Sun, 14 Dec 2025
WV Department of Health, EMD urge caution as temperatures drop - WBOY.com
Sat, 13 Dec 2025
EMD Associated With Poorer Outcomes in Previously Treated R/R Multiple Myeloma - CancerNetwork
Fri, 17 Oct 2025
In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program - BioSpace
Fri, 17 Oct 2025
EMD Serono partners US government to widen IVF access - Pharmaceutical Technology
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 58 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 47.9 (%) |
| Shares Short | 120 (K) |
| Shares Short P.Month | 138 (K) |
| EPS | 1.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.69 |
| Profit Margin | 115.9 % |
| Operating Margin | 87.7 % |
| Return on Assets (ttm) | 4.4 % |
| Return on Equity (ttm) | 13 % |
| Qtrly Rev. Growth | -1.7 % |
| Gross Profit (p.s.) | 1.18 |
| Sales Per Share | 1.18 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 104 % |
| Operating Cash Flow | 67 (M) |
| Levered Free Cash Flow | 36 (M) |
| PE Ratio | 7.81 |
| PEG Ratio | 0 |
| Price to Book value | 1 |
| Price to Sales | 9.06 |
| Price to Cash Flow | 9.36 |
| Dividend | 0.09 |
| Forward Dividend | 0 |
| Dividend Yield | 0.8% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|